How to Use ADMELOG®
ADMELOG is available in the ADMELOG SoloStar® pen. The SoloStar pen family is the most frequently used disposable single-patient-use injection pen. ADMELOG is also available in a vial and is approved for use in a pump.
ADMELOG is available in a prefilled disposable SoloStar pen
Features to help you select and inject your dose.
Uses a small, thin needle†
that goes just under the skin.
Dose selector dial and
work together so you can select
and inject your prescribed dose.
Large dose window
lets you clearly see your selected
dose. Each line in the dose window equals 1 unit of ADMELOG.
Ask for help if you have problems handling the pen, for example, if you have problems with your eyesight.
†Needle not included with pen; a separate prescription is needed. Always use needles compatible with your pen.
Helpful tips for using ADMELOG
ADMELOG gives you the option to dose 15 minutes before a meal or immediately after a meal so you can take the amount you need based on what you ate, not the other way around.
Before you use ADMELOG
Your healthcare provider should teach you how to inject ADMELOG. However, before you use your pen:
- Read all the information that came with your pen or vial, including the Instructions for Use.
- Speak with your doctor or healthcare provider if you have questions about your pen or vial, or do not understand the instructions.
Take special note
- Do not reuse needles.
- Do not use a syringe to remove medicine from your pen.
- Do not share your pen with other people, even if the needle has been changed.
- Check the label on the ADMELOG pen each time you inject to make sure you are using the correct medicine.
- If you have problems handling the pen or can’t see the numbers in the dose window clearly, have another person help you.
When to inject
ADMELOG should be given within 15 minutes before a meal or immediately after a meal.
Where to inject
You can inject ADMELOG in four areas of your body:
- Anywhere in your stomach area, except for a two-inch radius around your navel.
- In the fatty tissue on the outer back area of your upper arm.
- In your thigh, away from your knee.
- In your buttocks.
Take special note
Rotate your injection sites with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.
How to store your pen
Before first use
Keep new pens in the refrigerator between 36°F and 46°F (2°C and 8°C)
until the expiration date.
Discard expired pens.
Do not freeze.
Do not use ADMELOG
if it has been frozen.
of the reach
After first use
Keep your pen at
below 86°F (30°C).
Keep your pen
away from heat
of the reach
Store your pen with the pen cap on.
Do not store your pen with the needle attached.
Only use your pen for up to 28 days
after its first use. Throw away the ADMELOG SoloStar pen you are using after 28 days, even if it still has insulin left in it. Use an FDA-approved sharps disposal container right after use.
What is Admelog® (insulin lispro injection) 100 Units/mL?
Prescription Admelog is a fast-acting human insulin used to improve blood sugar control in adults with Type 2 diabetes and adults and children (3 years and older) with Type 1 diabetes.
Important Safety Information
Important Safety Information
Do not use Admelog if you have low blood sugar or if you are allergic to insulin lispro or any of the other ingredients in Admelog.
Do not share needles, insulin pens, or syringes with others, even if the needle is changed. Do NOT reuse needles. You may give other people a serious infection, or get a serious infection from them.
Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.
Before starting Admelog, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breastfeeding or planning to breastfeed.
Heart failure can occur if you are taking insulin together with pills called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Admelog. Your treatment with TZDs and Admelog may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms, including:
- Shortness of breath
- Sudden weight gain
- Swelling of your ankles or feet
Tell your doctor about all the medications you take, including OTC medicines, vitamins, supplements, and herbal supplements.
When used as a mealtime insulin, Admelog should be taken within 15 minutes before a meal or immediately after a meal. Test your blood sugar levels as directed by your doctor when using Admelog. Do not change your dose or type of insulin without talking to your doctor. Any change of insulin should be made cautiously and only under medical supervision.
Check your insulin label to verify that you have the correct insulin before each injection. Admelog must only be used if the solution is clear and colorless with no particles visible.
While using Admelog, do not drive or operate heavy machinery until you know how Admelog affects you. Do not drink alcohol or use medicines that contain alcohol.
Admelog may cause serious side effects that can lead to death, including:
|-||Low blood sugar (hypoglycemia). Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability or mood changes, hunger.|
|-||Serious allergic reactions. Get medical help right away if you have: a rash over your whole body, trouble breathing, fast heartbeat, feeling faint, or sweating.|
|-||Low potassium in your blood (hypokalemia). Your doctor should monitor you for low blood potassium levels.|
|-||Heart failure. Your doctor should monitor you closely while you are taking TZDs with Admelog.|
Get emergency medical help if you have:
- Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, confusion.
Admelog may have additional side effects including injection site reactions which may include change in fat tissue, skin thickening, redness, swelling and itching.
Important Safety Information for Admelog® (insulin lispro injection) SoloStar®
Admelog SoloStar is a disposable single-patient-use prefilled insulin pen. Talk to your doctor about proper injection technique and follow instructions in the Instruction Leaflet that comes with the pen.
Important Safety Information for Admelog (insulin lispro injection) when used in a pump
Do not mix or dilute Admelog when used in a pump.
Failure of your insulin pump or infusion set or degradation of the insulin in the pump can cause hyperglycemia and ketoacidosis. Always carry an alternate form of insulin administration in the case of pump failure.
All registered trademarks cited are property of their respective owners.
If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-16101-800-633-1610
The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.
*Eligibility Restrictions & Offer Terms:
Insulins Valyou Savings Program:
Sanofi insulins included in this program are: ADMELOG® (insulin lispro injection) 100 Units/mL, TOUJEO® SoloStar® (insulin glargine injection) 300 Units/mL, TOUJEO® Max SoloStar® (insulin glargine injection) 300 Units/mL, LANTUS® (insulin glargine injection) 100 Units/mL, INSULIN GLARGINE injection 100 Units/mL (U-100) and APIDRA® (insulin glulisine injection) 100 Units/mL.
Savings may vary depending on patients’ out-of-pocket costs. Upon registration, patients receive all program details. Sanofi US reserves the right to change the maximum cap amount, rescind, revoke, or amend the program without notice.